Portfolio company
Sensorion
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops gene therapies and small molecule drugs to restore, treat and prevent inner ear disorders for patients with hearing loss.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Akouos
The company develops gene therapies to restore, improve and preserve hearing for individuals with disabling sensorineural hearing loss.
Decibel Therapeutics
This biotechnology company develops gene therapies to restore hearing and balance for patients with congenital hearing loss and related genetic disorders.
CamGene Therapeutics
This biotechnology company develops RNA-based medicines and lipid nanoparticle delivery technologies to treat hearing loss for patients with cellular dysfunction or cochlear implants.
GenSight Biologics
This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.
CamGene
This company develops RNA-based therapeutics using lipid nanoparticle technology to treat hearing loss for patients with cellular dysfunction or undergoing cochlear implant surgery.
Atsena
This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.
Beacon Therapeutics
This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.
Sparing Vision
This genomic medicine company develops mutation-agnostic gene therapies to preserve and restore sight for patients with blinding inherited retinal diseases.